Almirall has received a 15 million dollar payment from Forest Laboratories in connection with its phase III development of aclidinium bromide, an antimuscarinic for the treatment of COPD (Chronic Obst… more →
GPCR Newswrote 1 year ago: Almirall has received a 15 million dollar payment from Forest Laboratories in connection with its ph … more →